Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trialVincent J-L, Spapen HDMH, Creteur J, et al (Free Univ of Brussels, Belgium; Academisch Ziekenhuis van de Vrije Universiteit Brussel, Belgium; Univ of Brussels, Belgium; et al) Crit Care Med 34:1661–1667, 2006§